Accès à distance ? S'identifier sur le proxy UCLouvain
Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"? Reply
Primary tabs
Jacobs, Bart
[UCL]
Piessevaux, Hubert
[UCL]
De Roock, Wendy
[UCL]
Biesmans, Bart
[UCL]
De Schutter, Jef
[UCL]
Claes, Bart
[UCL]
Tejpar, Sabine
[UCL]
De Roock, Wendy
[UCL]
Biesmans, Bart
[UCL]
De Schutter, Jef
[UCL]
Claes, Bart
[UCL]
Tejpar, Sabine
[UCL]
| Document type | Article de périodique (Journal article) – Lettre à l'éditeur |
|---|---|
| Publication date | 2010 |
| Language | Anglais |
| Journal information | "Journal of Clinical Oncology" - Vol. 28, no. 11, p. E175-E176 (2010) |
| Peer reviewed | yes |
| Publisher | Amer Soc Clinical Oncology (Alexandria) |
| issn | 0732-183X |
| e-issn | 1527-7755 |
| Publication status | Publié |
| Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - SSS/IREC - Institut de recherche expérimentale et clinique |
| Links |
| Bibliographic reference | Jacobs, Bart ; Piessevaux, Hubert ; De Roock, Wendy ; Biesmans, Bart ; De Schutter, Jef ; et. al. Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"? Reply. In: Journal of Clinical Oncology, Vol. 28, no. 11, p. E175-E176 (2010) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/33967 |